425 related articles for article (PubMed ID: 34260978)
1. Prognostic significance of bronchoalveolar lavage cellular analysis in patients with acute exacerbation of interstitial lung disease.
Kono M; Miyashita K; Hirama R; Oshima Y; Takeda K; Mochizuka Y; Tsutsumi A; Miwa H; Miki Y; Hashimoto D; Suda T; Nakamura H
Respir Med; 2021 Sep; 186():106534. PubMed ID: 34260978
[TBL] [Abstract][Full Text] [Related]
2. Bronchoalveolar lavage differential cell count on prognostic assessment of patients with stable or acute interstitial lung disease: A retrospective real-life study.
Salonen J; Lampela H; Keskitalo E; Vähänikkilä H; Purokivi M; Kaarteenaho R
Clin Immunol; 2020 Nov; 220():108594. PubMed ID: 32927080
[TBL] [Abstract][Full Text] [Related]
3. Prognosis after acute exacerbation in patients with interstitial lung disease other than idiopathic pulmonary fibrosis.
Miyashita K; Kono M; Saito G; Koyanagi Y; Tsutsumi A; Kobayashi T; Miki Y; Hashimoto D; Nakamura Y; Suda T; Nakamura H
Clin Respir J; 2021 Mar; 15(3):336-344. PubMed ID: 33197284
[TBL] [Abstract][Full Text] [Related]
4. S100A9 in BALF is a candidate biomarker of idiopathic pulmonary fibrosis.
Hara A; Sakamoto N; Ishimatsu Y; Kakugawa T; Nakashima S; Hara S; Adachi M; Fujita H; Mukae H; Kohno S
Respir Med; 2012 Apr; 106(4):571-80. PubMed ID: 22209187
[TBL] [Abstract][Full Text] [Related]
5. Acute exacerbations of fibrosing interstitial lung disease associated with connective tissue diseases: a population-based study.
Cao M; Sheng J; Qiu X; Wang D; Wang D; Wang Y; Xiao Y; Cai H
BMC Pulm Med; 2019 Nov; 19(1):215. PubMed ID: 31727051
[TBL] [Abstract][Full Text] [Related]
6. Impact of lymphocyte differential count > 15% in BALF on the mortality of patients with acute exacerbation of chronic fibrosing idiopathic interstitial pneumonia.
Takei R; Arita M; Kumagai S; Ito Y; Noyama M; Tokioka F; Ishida T
BMC Pulm Med; 2017 Apr; 17(1):67. PubMed ID: 28427425
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic and prognostic biomarkers for progressive fibrosing interstitial lung disease.
Watase M; Mochimaru T; Kawase H; Shinohara H; Sagawa S; Ikeda T; Yagi S; Yamamura H; Matsuyama E; Kaji M; Kurihara M; Sato M; Horiuchi K; Watanabe R; Nukaga S; Irisa K; Satomi R; Oyamada Y
PLoS One; 2023; 18(3):e0283288. PubMed ID: 36930615
[TBL] [Abstract][Full Text] [Related]
8. Serum and bronchoalveolar lavage fluid levels of soluble B7H3 in patients with interstitial lung diseases.
Nakashima T; Omori K; Namba M; Yamaguchi K; Sakamoto S; Horimasu Y; Masuda T; Miyamoto S; Iwamoto H; Fujitaka K; Hamada H; Hattori N
Respir Med; 2023 Jun; 212():107224. PubMed ID: 37003499
[TBL] [Abstract][Full Text] [Related]
9. Comparison of clinical courses and mortality of connective tissue disease-associated interstitial pneumonias and chronic fibrosing idiopathic interstitial pneumonias.
Yıldırım F; Türk M; Bitik B; Erbaş G; Köktürk N; Haznedaroğlu Ş; Türktaş H
Kaohsiung J Med Sci; 2019 Jun; 35(6):365-372. PubMed ID: 30913371
[TBL] [Abstract][Full Text] [Related]
10. BAL in the diagnosis of smoking-related interstitial lung diseases: review of literature and analysis of our experience.
Domagała-Kulawik J
Diagn Cytopathol; 2008 Dec; 36(12):909-15. PubMed ID: 18855907
[TBL] [Abstract][Full Text] [Related]
11. CXCL9, CXCL10, and CXCL11; biomarkers of pulmonary inflammation associated with autoimmunity in patients with collagen vascular diseases-associated interstitial lung disease and interstitial pneumonia with autoimmune features.
Kameda M; Otsuka M; Chiba H; Kuronuma K; Hasegawa T; Takahashi H; Takahashi H
PLoS One; 2020; 15(11):e0241719. PubMed ID: 33137121
[TBL] [Abstract][Full Text] [Related]
12. The role of interleukin-6 as a prognostic biomarker for predicting acute exacerbation in interstitial lung diseases.
Lee JH; Jang JH; Park JH; Jang HJ; Park CS; Lee S; Kim SH; Kim JY; Kim HK
PLoS One; 2021; 16(7):e0255365. PubMed ID: 34314462
[TBL] [Abstract][Full Text] [Related]
13. CCL18 in serum, BAL fluid and alveolar macrophage culture supernatant in interstitial lung diseases.
Cai M; Bonella F; He X; Sixt SU; Sarria R; Guzman J; Costabel U
Respir Med; 2013 Sep; 107(9):1444-52. PubMed ID: 23831213
[TBL] [Abstract][Full Text] [Related]
14. Clinical features and outcome of acute exacerbation in connective tissue disease-associated interstitial lung disease: A single-center study from India.
Singh P; Thakur B; Mohapatra AK; Padhan P
Int J Rheum Dis; 2019 Sep; 22(9):1741-1745. PubMed ID: 31328423
[TBL] [Abstract][Full Text] [Related]
15. Prognostic evaluation by oxygenation with positive end-expiratory pressure in acute exacerbation of idiopathic pulmonary fibrosis: A retrospective cohort study.
Suzuki A; Taniguchi H; Ando M; Kondoh Y; Kimura T; Kataoka K; Matsuda T; Yokoyama T; Sakamoto K; Hasegawa Y
Clin Respir J; 2018 Mar; 12(3):895-903. PubMed ID: 28026113
[TBL] [Abstract][Full Text] [Related]
16. [The expression and clinical role of KL-6 in serum and BALF of patients with different diffuse interstitial lung diseases].
Zhu C; Zhao YB; Kong LF; Li ZH; Kang J
Zhonghua Jie He He Hu Xi Za Zhi; 2016 Feb; 39(2):93-7. PubMed ID: 26879611
[TBL] [Abstract][Full Text] [Related]
17. Bronchoalveolar lavage total cell count in interstitial lung diseases--does it matter?
Domagała-Kulawik J; Skirecki T; Maskey-Warzechowska M; Grubek-Jaworska H; Chazan R
Inflammation; 2012 Jun; 35(3):803-9. PubMed ID: 21882075
[TBL] [Abstract][Full Text] [Related]
18. Elevated serum D-dimer level is associated with an increased risk of acute exacerbation in interstitial lung disease.
Ishikawa G; Acquah SO; Salvatore M; Padilla ML
Respir Med; 2017 Jul; 128():78-84. PubMed ID: 28610674
[TBL] [Abstract][Full Text] [Related]
19. Prognosis and causes of death of patients with acute exacerbation of fibrosing interstitial lung diseases.
Salonen J; Purokivi M; Bloigu R; Kaarteenaho R
BMJ Open Respir Res; 2020 Apr; 7(1):. PubMed ID: 32265195
[TBL] [Abstract][Full Text] [Related]
20. The diagnostic value of the bronchoalveolar lavage in interstitial lung diseases.
Efared B; Ebang-Atsame G; Rabiou S; Diarra AS; Tahiri L; Hammas N; Smahi M; Amara B; Benjelloun MC; Serraj M; Chbani L; El Fatemi H
J Negat Results Biomed; 2017 Mar; 16(1):4. PubMed ID: 28245857
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
